BRAF and atrial fibrillation: There is a demonstrable risk of myocardial infarction, atrial fibrillation, and QTc prolongation with BRAF inhibitor therapy which is theorized to be caused by a BRAF-mediated alteration of the myocardial repolarization process (91).